TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07140783: OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity

Sponsor: Opus Genetics, Inc · Phase: PHASE3 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 580 pts

Competing Trials Overlap

13 Active Trials

Excess Burn Exposure

$2,734,352

Rescue Site Savings

+$1,791,472

Unlock Full NCT07140783 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07140783 Rescue Dossier →